IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

被引：0

作者：

Miller, M. ^{[1
]}

Sahin, U. ^{[2
]}

Derhovanessian, E. ^{[3
]}

Kloke, B-P. ^{[1
]}

Simon, P. ^{[4
]}

Bukur, V. ^{[5
]}

Albrecht, C. ^{[6
]}

Paruzynski, A. ^{[5
]}

Loewer, M. ^{[7
]}

Kuhn, A. ^{[8
]}

Schreeb, K. ^{[9
]}

Attig, S. ^{[10
]}

Brueck, A. Kemmer ^{[9
]}

Bolte, S. ^{[9
]}

Grabbe, S. ^{[11
]}

Hoeller, C. ^{[12
]}

Utikal, J. ^{[13
]}

Huber, C. ^{[14
]}

Loquai, C. ^{[11
]}

Tuereci, O. ^{[15
]}

机构：

[1] Biopharmaceut New Technol BioNTech Corp, Project Management, Mainz, Germany

[2] Biopharmaceut New Technol BioNTech Corp, Management, Mainz, Germany

[3] Biopharmaceut New Technol BioNTech Corp, Immunomonitoring, Mainz, Germany

[4] Biopharmaceut New Technol BioNTech Corp, Immunoreceptor Validat, Mainz, Germany

[5] Biopharmaceut New Technol BioNTech Corp, Genom, Mainz, Germany

[6] Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, Genom, Mainz, Germany

[7] Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, Bioinformat, Mainz, Germany

[8] Biopharmaceut New Technol BioNTech Corp, RNA Biochem, Mainz, Germany

[9] Biopharmaceut New Technol BioNTech Corp, Clin Res, Mainz, Germany

[10] Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, Immunmonitoring, Mainz, Germany

[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dermatol, Mainz, Germany

[12] Med Univ Vienna, Dermatol, Vienna, Austria

[13] German Canc Res Ctr, Dermatol, Heidelberg, Germany

[14] Biopharmaceut New Technol BioNTech Corp, Advisory Board, Mainz, Germany

[15] CI3 Cluster Individualized Immunointervent, Management, Mainz, Germany

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[21] First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial [J].

Streby, Keri A. ;

Currier, Mark A. ;

Triplet, Melinda ;

Ott, Kristy ;

Dishman, Devon J. ;

Vaughan, Michele R. ;

Ranalli, Mark A. ;

Setty, Bhuvana ;

Skeens, Micah A. ;

Whiteside, Stacy ;

Yeager, Nicholas D. ;

Haworth, Kellie B. ;

Simpson, Kathleen ;

Conner, Joe ;

Cripe, Timothy P. .

MOLECULAR THERAPY, 2019, 27 (11) :1930-1938

[22] Safety and efficacy of first-in-human intrathecal transplantation of human astrocytes (AstroRx®) in ALS patients: Phase I/IIA clinical trial results [J].

Izrael, Michal ;

Gotkine, Marc ;

Slutsky, Guy ;

Lerner, Yossef ;

Chebath, Judith ;

Kuperstein, Graciela ;

Estrin, Elena ;

Caraco, Yoseph ;

Ben-Hur, Tamir ;

Hasson, Arik ;

Sonnefeld, Tehila ;

Stark, Yafit ;

Revel, Ariel ;

Revel, Michel .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 :256-256

[23] Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials [J].

Hansen, Aaron R. ;

Cook, Natalie ;

Ricci, M. Stacey ;

Razak, Albiruni ;

Le Tourneau, Christophe ;

McKeever, Kathleen ;

Roskos, Lorin ;

Dixit, Rakesh ;

Siu, Lillian L. ;

Hinrichs, Mary Jane .

ONCOLOGIST, 2015, 20 (06) :653-659

[24] First-in-human phase I trial of NHS-IL12 in advanced solid tumors [J].

Kim, Joseph W. ;

Heery, Christopher Ryan ;

Bilusic, Marijo ;

Singh, Nishith K. ;

Madan, Ravi A. ;

Sabzevari, Helen ;

Schlom, Jeffrey ;

Gulley, James L. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[25] An Open-Label, First-in-Human, Phase I Trial of Daily Pclx-001 [J].

Sangha, Randeep ;

Mackey, John R. ;

Sehn, Laurie H. ;

Kuruvilla, John ;

Weickert, Michael J. ;

Berthiaume, Luc G. .

BLOOD, 2021, 138

[26] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas [J].

Hong, David S. ;

Kurzrock, Razelle ;

Supko, Jeffrey G. ;

He, Xiaoying ;

Naing, Aung ;

Wheler, Jennifer ;

Lawrence, Donald ;

Eder, Joseph Paul ;

Meyer, Colin J. ;

Ferguson, Deborah A. ;

Mier, James ;

Konopleva, Marina ;

Konoplev, Sergej ;

Andreeff, Michael ;

Kufe, Donald ;

Lazarus, Hillard ;

Shapiro, Geoffrey I. ;

Dezube, Bruce J. .

CLINICAL CANCER RESEARCH, 2012, 18 (12) :3396-3406

[27] Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial [J].

Kashihara, Tairo ;

Nakamura, Satoshi ;

Yamazaki, Naoya ;

Takahashi, Akira ;

Namikawa, Kenjiro ;

Ogata, Dai ;

Nakano, Eiji ;

Okuma, Kae ;

Kaneda, Tomoya ;

Mori, Taisuke ;

Ito, Kimiteru ;

Itami, Jun ;

Shimada, Kazuaki ;

Nakagama, Hitoshi ;

Igaki, Hiroshi .

RADIOTHERAPY AND ONCOLOGY, 2025, 202

[28] Choice of starting dose for biopharmaceuticals in first-in-human phase I cancer clinical trials. [J].

Hansen, Aaron Richard ;

Cook, Natalie ;

Ricci, M. Stacey ;

Razak, Albiruni R. A. ;

Le Tourneau, Christophe ;

McKeever, Kathleen ;

Roskos, Lorin ;

Dixit, Rakesh ;

Siu, Lillian L. ;

Hinrichs, Mary Jane .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[29] A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001 [J].

Sangha, Randeep ;

Sehn, Laurie H. ;

Jamal, Rahima ;

Spratlin, Jennifer ;

Kuruvilla, John ;

Weickert, Michael J. ;

Berthiaume, Luc G. ;

Mackey, John R. .

BLOOD, 2022, 140 :12057-12058

[30] First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers [J].

Hernandez-Jimenez, Macarena ;

Martin-Vilchez, Samuel ;

Ochoa, Dolores ;

Mejia-Abril, Gina ;

Roman, Manuel ;

Camargo-Mamani, Paola ;

Luquero-Bueno, Sergio ;

Jilma, Bernd ;

Moro, Maria A. ;

Fernandez, Geronimo ;

Pineiro, David ;

Ribo, Marc ;

Gonzalez, Victor M. ;

Lizasoain, Ignacio ;

Abad-Santos, Francisco .

MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 :124-135

← 1 2 3 4 5 →